RECURSION PHARMACEUTICALS IN

Q1 2026 13F Holders

CUSIP
75629V904
Type
Equity
Class
CALL
Num filings
4
Total reported value, excl. options
$286 k
Manager Report Date Value ($000) Shares Option Type